Rudolph et al.
2015
Inhibitors of p21-activated kinases (PAKs) miniperspective
McKernan et al.
2012
Protein kinase C: one pathway towards the eradication of latent HIV‐1 reservoirs
Karin et al.
2004
The IKK NF-κB system: a treasure trove for drug development
RS20050430A
(en )
2007-08-03
2-(1h-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophtalmic diseases
Chmurska et al.
2021
Two faces of autophagy in the struggle against cancer
HUP0203965A2
(en )
2003-05-28
Indazole compounds and pharmaceutical compositions containing them
CY1107148T1
(el )
2012-01-25
Παραγωγα ινδαζολης και φαρμακευτικες συνθεσεις για αναστολη των κινασων πρωτεϊνης και μεθοδοι για τη χρηση τους
BRPI0410563A
(pt )
2006-06-20
derivados de pirazol-quinazolina processo para sua preparação e seu uso como inibidores de quinase
SV2003001148A
(es )
2003-03-18
Derivados de benzamida tiazol y composciones farmaceuticas para inhibir la proliferacion de celulas, y metodos para su utilizacion ref. no.0097-01-sv
EA201070167A1
(ru )
2013-07-30
Замещенные производные индазола, активные как ингибиторы киназы
EA200400953A1
(ru )
2005-06-30
Замещённые пиридиноны в качестве модуляторов map-киназы p38
Dent et al.
2020
Neratinib degrades MST4 via autophagy that reduces membrane stiffness and is essential for the inactivation of PI3K, ERK1/2, and YAP/TAZ signaling
BR0312722A
(pt )
2005-05-10
Derivados de pirazol heterobicìclico como inibidores de qinase
BRPI0517921A
(pt )
2008-10-21
métodos para preparar compostos de indazol
Ciarlantini et al.
2021
Development of an Improved Guanidine‐Based Rac1 Inhibitor with in vivo Activity against Non‐Small Cell Lung Cancer
CN109640970A
(zh )
2019-04-16
具有内皮稳定化活性和抗炎活性的非催化底物选择性p38α特异性MAPK抑制剂及其使用方法
Hatcher et al.
2020
Discovery of a selective, covalent IRAK1 inhibitor with antiproliferative activity in MYD88 mutated B-cell lymphoma
Berabez et al.
2022
LIM kinases, promising but reluctant therapeutic targets: chemistry and preclinical validation in vivo
EA200401319A1
(ru )
2005-04-28
Новые гетероциклические соединения, способы их получения и фармацевтические композиции, содержащие эти соединения, и их использование в медицине
Kekeçmuhammed et al.
2023
Synthesis, Biological Activity Evaluation and Molecular Docking of imidazole derivatives possessing hydrazone moiety
Mancini et al.
2009
14‐3‐3 ligand prevents nuclear import of c‐ABL protein in chronic myeloid leukemia
TH68221A
(enrdf_load_html_response )
2005-04-20
Dravecka et al.
2025
Low extracellular pH protects cancer cells from ammonia toxicity
Mao et al.
2006
JWA is required for the antiproliferative and pro‐apoptotic effects of all‐trans retinoic acid in Hela cells
Osmaniye et al.
2023
Synthesis of Imidazole‐2, 3‐dihydrothiazole Compounds as VEGFR‐2 inhibitors and their support with in silico studies